Company Monitoring Page for OPKO-Health

latest headlines for company on cafepharma

Pfizer partner Opko reports a PhIII failure for growth hormone, but tries to steer out of a crash
Endpoints
Fri, 12/30/16 - 10:34 am
Tags:
Pfizer, OPKO Health, growth hormone, clinical trials
4 US pharma execs make Forbes 400 list
BioPharma Dive
Wed, 10/19/16 - 06:47 pm
Tags:
Patrick Soon-Shiong, NantWorks, Phillip Frost, OPKO Health, Randal Kirk, Intrexon, Robert Duggan, Pharmacyclics
Opko wins approval for kidney drug after manufacturing snag
BioPharma Dive
Thu, 06/23/16 - 08:13 pm
Tags:
OPKO Health, Rayaldee, FDA, secondary hyperparathyroidism, kidney disease
OPKO Health posts first-quarter loss of $12 million
Yahoo/AP
Mon, 05/9/16 - 09:50 pm
Tags:
OPKO Health, earnings
Top 6 Biopharma Movers of the Past Week
24/7 Wall St
Mon, 04/4/16 - 07:56 am
Tags:
Genocea Biosciences, OPKO Health, ContraVir, Inovio, Acadia, Apricus Biosciences
Opko Health stock falls 10% after drug approval faces delay
Bizjournals.com
Wed, 03/30/16 - 09:21 pm
Tags:
FDA, OPKO Health, Rayaldee, kidney disease
5 Key FDA Decisions Expected in March
24/7 Wall St
Mon, 03/14/16 - 10:02 am
Tags:
FDA, Rayaldee, OPKO Health, Nuplazid, Acadia, abaloparatide, Radius Health, pegvaliase, Biomarin, ALD403, Alder Biopharmaceuticals
3 Biotech Companies With Recent Large Insider Buying
Yahoo/Benzinga
Wed, 03/2/16 - 10:54 am
Tags:
biotech, OPKO Health, Seattle Genetics, Intra-Cellular Therapies
Opko Health's New Era Begins
Motley Fool
Sat, 11/21/15 - 12:26 pm
Tags:
OPKO Health, Rayaldee, chronic kidney disease
5 Big FDA Decisions Expected in September
24/7 Wall St
Sun, 08/30/15 - 02:08 pm
Tags:
FDA, rolapitant, OPKO Health, Tesaro, Zosano, ZP-Glucagon, XenoPort, XP23829, Apricus Biosciences, RayVa
FDA Accepts OPKO’s New Drug Application for Rayaldee
Yahoo
Wed, 07/29/15 - 10:10 am
Tags:
FDA, OPKO Health, secondary hyperparathyroidism, Rayaldee
Pfizer's Next-Generation Human Growth Hormone Takes a Step Forward
Motley Fool
Sat, 07/11/15 - 10:30 am
Tags:
Pfizer, OPKO Health, HGH, human growth hormone, hGH-CTP, human growth hormone deficiency
The Biotech Drug Lord: How One Man Is Conquering The Biotech Space
Motley Fool
Sun, 06/28/15 - 11:47 am
Tags:
biotech, OPKO Health
The latest healthcare merger has sent this stock through the roof
Yahoo/Business Insider
Thu, 06/4/15 - 11:36 am
Tags:
OPKO Health, BioReference Labs, M&A
An Attractive M&A Play In The Busy Biotech Space
Forbes
Thu, 05/14/15 - 09:55 am
Tags:
M&A, biotech, OPKO Health, EirGen Phama
Pfizer, Inc. Invests in Growth... Literally
Motley Fool
Wed, 12/17/14 - 08:26 am
Tags:
Pfizer, OPKO Health, human growth hormone
OPKO and Pfizer Enter into Global Agreement for OPKO’s Long-Acting Human Growth Hormone (hGH-CTP)
Yahoo
Mon, 12/15/14 - 08:23 am
Tags:
Pfizer, OPKO Health, human growth hormone, hGH-CTP
Biotech's 3 Most Influential CEOs
Motley Fool
Thu, 11/20/14 - 10:54 am
Tags:
biotech, Ivax, Teva Pharmaceutical, Phillip Frost, OPKO Health, Chris Viehbacher, Sanofi, Gilead Sciences, John C. Martin
Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
Motley Fool
Thu, 04/3/14 - 09:21 am
Tags:
Medicines Company, Omeros, OPKO Health, Vivus, OMS721, Qsymia, Fibrocaps
Zerenex- The New Spark For Keryx?
Seeking Alpha
Mon, 11/25/13 - 10:57 am
Tags:
Zerenex, Keryx, Sanofi, OPKO Health

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.